Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Jun. 30, 2015
Current assets:
Cash	$ 395,000	$ 71,000
Accounts receivable, net	3,135,000	2,638,000
Inventories	7,756,000	5,778,000
Investment in iBio, Inc.	501,000	501,000
Other current assets	283,000	334,000
Total current assets	12,070,000	9,322,000
Intangible assets, net	235,000	743,000
Property and equipment, net	1,567,000	1,373,000
Security deposits and other assets	213,000	185,000
Total assets	14,085,000	11,623,000
Current liabilities:
Advances under revolving credit facility	4,210,000	4,462,000
Accounts payable (includes $331 and $290 due to a related party for 2016 and 2015)	5,469,000	5,148,000
Accrued expenses and other current liabilities	1,211,000	1,536,000
Current portion of long term debt	934,000	719,000
Total current liabilities	11,824,000	11,865,000
Long term debt	5,306,000	3,942,000
Subordinated convertible note, net - CD Financial, LLC	5,206,000	5,120,000
Derivative liabilities	76,000	12,000
Total liabilities	22,412,000	20,939,000
Commitments and contingencies
Stockholders' deficiency:
Common Stock, par value $0.002 per share; shares authorized 50,000,000; shares issued and outstanding were 21,140,074 and 21,105,174, respectively	42,000	42,000
Additional paid-in-capital	44,707,000	44,676,000
Accumulated deficit	(52,977,000)	(53,935,000)
Less: Treasury stock, at cost, 34,900 shares	(99,000)	(99,000)
Total stockholders' deficiency	(8,327,000)	(9,316,000)
Total liabilities and stockholders' deficiency	$ 14,085,000	$ 11,623,000